Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muller Fabbri

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2010
High-throughput profiling in the hematopoietic systemMuller Fabbri, Riccardo Spizzo, George A Calin
Nature Reviews. Drug Discovery|November 1, 2013
MicroRNAs and other non-coding RNAs as targets for anticancer drug developmentHui Ling, Muller Fabbri, George A Calin
Cancers|July 5, 2017
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic ApplicationsLorenzo F Sempere, Jessica Keto, Muller Fabbri
Carcinogenesis|March 19, 2009
MicroRNAs and genomic variations: from Proteus tricks to Prometheus giftMuller Fabbri, Nicola Valeri, George A Calin
Cancer Genomics & Proteomics|August 7, 2009
Pathogenetic and clinical relevance of microRNAs in colorectal cancerNicola Valeri, Carlo M Croce, Muller Fabbri
Plos One|January 11, 2022
Overexpression of ultraconserved region 83- induces lung cancer tumorigenesisIvan Vannini, Manuela Ferracin, Francesco Fabbri, et al.
Seminars in Oncology|November 16, 2011
Clinical implications of microRNAs in lung cancerFrancesca Fanini, Ivan Vannini, Dino Amadori, et al.
Proteomics|September 24, 2017
Mechanisms of Drug Resistance in Cancer: The Role of Extracellular VesiclesPriya Samuel, Muller Fabbri, David Raul Francisco Carter
Immunotherapy|October 4, 2013
Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic reviewSeyed Hossein Aalaei-Andabili, Muller Fabbri, Nima Rezaei
JAMA|June 9, 2025
Incorrect Immunoblot in Figure Showing TP53 Downstream Effectors in Cell Lines and Primary B-Cell Chronic Lymphocytic Leukemia SamplesMuller Fabbri, George A Calin, Carlo M Croce
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2010
High-throughput profiling in the hematopoietic systemMuller Fabbri, Riccardo Spizzo, George A Calin
Nature Reviews. Drug Discovery|November 1, 2013
MicroRNAs and other non-coding RNAs as targets for anticancer drug developmentHui Ling, Muller Fabbri, George A Calin
Cancers|July 5, 2017
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic ApplicationsLorenzo F Sempere, Jessica Keto, Muller Fabbri
Carcinogenesis|March 19, 2009
MicroRNAs and genomic variations: from Proteus tricks to Prometheus giftMuller Fabbri, Nicola Valeri, George A Calin
Cancer Genomics & Proteomics|August 7, 2009
Pathogenetic and clinical relevance of microRNAs in colorectal cancerNicola Valeri, Carlo M Croce, Muller Fabbri
Plos One|January 11, 2022
Overexpression of ultraconserved region 83- induces lung cancer tumorigenesisIvan Vannini, Manuela Ferracin, Francesco Fabbri, et al.
Seminars in Oncology|November 16, 2011
Clinical implications of microRNAs in lung cancerFrancesca Fanini, Ivan Vannini, Dino Amadori, et al.
Proteomics|September 24, 2017
Mechanisms of Drug Resistance in Cancer: The Role of Extracellular VesiclesPriya Samuel, Muller Fabbri, David Raul Francisco Carter
Immunotherapy|October 4, 2013
Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic reviewSeyed Hossein Aalaei-Andabili, Muller Fabbri, Nima Rezaei
JAMA|June 9, 2025
Incorrect Immunoblot in Figure Showing TP53 Downstream Effectors in Cell Lines and Primary B-Cell Chronic Lymphocytic Leukemia SamplesMuller Fabbri, George A Calin, Carlo M Croce
Pageof 11